Robin Stevenson

Direktor/Vorstandsmitglied bei Avelas Biosciences, Inc.

Health Technology

Health Services

Profil

Robin Stevenson is currently a Non-Executive Director at Avelas Biosciences, Inc. He started this position in 2021 and is still currently employed there.
Prior to this, he was a Director at The Breast Cancer Research Trust.

Aktive Positionen von Robin Stevenson

Unternehmen	Position	Beginn
Avelas Biosciences, Inc. Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA.	Direktor/Vorstandsmitglied	18.10.2021

Alle aktiven Positionen von Robin Stevenson

Ehemalige bekannte Positionen von Robin Stevenson

Unternehmen	Position	Ende
The Breast Cancer Research Trust The Breast Cancer Research Trust Medical SpecialtiesHealth Technology The Breast Cancer Research Trust operates as not-for profit organization. It provides breast cancer treatment solutions. The company was founded in 1997 and is headquartered in Auckland, New Zealand.	Direktor/Vorstandsmitglied	-

Sehen Sie sich die Erfahrung von Robin Stevenson im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Robin Stevenson im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
The Breast Cancer Research Trust The Breast Cancer Research Trust Medical SpecialtiesHealth Technology The Breast Cancer Research Trust operates as not-for profit organization. It provides breast cancer treatment solutions. The company was founded in 1997 and is headquartered in Auckland, New Zealand.	Health Technology
Avelas Biosciences, Inc. Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA.	Health Services